Literature DB >> 12370352

Direct priming and cross-priming contribute differentially to the induction of CD8+ CTL following exposure to vaccinia virus via different routes.

Xuefei Shen1, S B Justin Wong, Christopher B Buck, Jiangwen Zhang, Robert F Siliciano.   

Abstract

To explore the relative importance of direct presentation vs cross-priming in the induction of CTL responses to viruses and viral vectors, we generated a recombinant vaccinia vector, vUS11, expressing the human CMV (HCMV) protein US11. US11 dislocates most allelic forms of human and murine MHC class I heavy chains from the lumen of the endoplasmic reticulum into the cytosol, where they are degraded by proteasomes. Expression of US11 dramatically decreased the presentation of viral Ag and CTL recognition of infected cells in vitro without significantly reducing total cell surface MHC class I levels. However, because US11 is an endoplasmic reticulum resident membrane protein, it cannot block presentation by non-infected cells that take up Ag through the cross-priming pathway. We show that the expression of US11 strongly inhibits the induction of primary CD8(+) CTLs when the infection occurs via the i.p. or i.v. route, demonstrating that direct priming is critical for the induction of CTL responses to viral infections introduced via these routes. This effect is less dramatic following i.m. infection and is minimal after s.c. or intradermal infection. Thus, classic MHC class I Ag presentation and cross-priming contribute differentially to the induction of CD8(+) CTLs following exposure to vaccinia virus via different routes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12370352     DOI: 10.4049/jimmunol.169.8.4222

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

1.  Infection of nonhost species dendritic cells in vitro with an attenuated myxoma virus induces gene expression that predicts its efficacy as a vaccine vector.

Authors:  S Top; E Foulon; B Pignolet; M Deplanche; C Caubet; C Tasca; S Bertagnoli; G Meyer; G Foucras
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

Review 2.  Duality at the gate: Skin dendritic cells as mediators of vaccine immunity and tolerance.

Authors:  Christopher J Nirschl; Niroshana Anandasabapathy
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

Review 3.  Initiation of primary anti-vaccinia virus immunity in vivo.

Authors:  Matthew A Fischer; Christopher C Norbury
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 4.  Activation and trafficking of CD8+ T cells during viral skin infection: immunological lessons learned from vaccinia virus.

Authors:  Samuel J Hobbs; Jossef F Osborn; Jeffrey C Nolz
Journal:  Curr Opin Virol       Date:  2017-10-25       Impact factor: 7.090

Review 5.  Viruses as vaccine vectors for infectious diseases and cancer.

Authors:  Simon J Draper; Jonathan L Heeney
Journal:  Nat Rev Microbiol       Date:  2010-01       Impact factor: 60.633

6.  Viral MHC class I inhibition evades CD8+ T-cell effector responses in vivo but not CD8+ T-cell priming.

Authors:  Maria D Gainey; Joshua G Rivenbark; Hyelim Cho; Liping Yang; Wayne M Yokoyama
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-29       Impact factor: 11.205

7.  Dendritic cells cross-present HIV antigens from live as well as apoptotic infected CD4+ T lymphocytes.

Authors:  Concepción Marañón; Jean-François Desoutter; Guillaume Hoeffel; William Cohen; Daniel Hanau; Anne Hosmalin
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-12       Impact factor: 11.205

8.  Original encounter with antigen determines antigen-presenting cell imprinting of the quality of the immune response in mice.

Authors:  Valérie Abadie; Olivia Bonduelle; Darragh Duffy; Christophe Parizot; Bernard Verrier; Béhazine Combadière
Journal:  PLoS One       Date:  2009-12-07       Impact factor: 3.240

9.  Direct presentation is sufficient for an efficient anti-viral CD8+ T cell response.

Authors:  Ren-Huan Xu; Sanda Remakus; Xueying Ma; Felicia Roscoe; Luis J Sigal
Journal:  PLoS Pathog       Date:  2010-02-12       Impact factor: 6.823

10.  Regulation of maturation and activating potential in CD8+ versus CD8- dendritic cells following in vivo infection with vaccinia virus.

Authors:  Rama D Yammani; Sharmila Pejawar-Gaddy; Thaddeus C Gurley; Eric T Weimer; Elizabeth M Hiltbold; Martha A Alexander-Miller
Journal:  Virology       Date:  2008-06-30       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.